Factors affecting use of magnesium sulphate for pre-eclampsia or eclampsia: a qualitative evidence synthesis.

ABSTRACT:

Background

Hypertensive disorders account for 14% of global maternal deaths. Magnesium sulphate (MgSO₄ ) is recommended for prevention and treatment of pre-eclampsia/eclampsia. However, MgSO₄ remains underused, particularly in low- and middle-income countries (LMICs).

Objective

This qualitative evidence synthesis explores perceptions and experiences of healthcare providers, administrators and policy-makers regarding factors affecting use of MgSO₄ to prevent or treat pre-eclampsia/eclampsia.

Search strategy

We searched MEDLINE, EMBASE, Emcare, CINAHL, Global Health and Global Index Medicus, and grey literature for studies published between January 1995 and June 2021.

Selection criteria

Primary qualitative and mixed-methods studie

SUBMITTER: Eddy KE 

PROVIDER: S-EPMC9291451 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature